Audited financial results for quarter and year ended March 31, 2026 along with report of statutory auditors.

IBL Indrayani Biotech Inclusive Growth Date: 17.08.2026 BSE Limited, Dept. of Corporate Services, Floor 25, P] Towers, Dalal Street, Mumbai-400001. Scrip Code: 526445 Dear Sir/ Madam Subject: Outcome of the Board Meeting. Ref: Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to our intimation letter dated August 12, 2026 under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that at the meeting of Board of Directors held today i.e., on Monday, August 17, 2026, the Directors have inter-alia, approved the Audited Financial Results (Standalone and Consolidated) with the Auditors Report for the quarter and year ended March 31, 2026 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements} Regulations, 2015. We have attached herewith the copy of the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. The Board Meeting commenced at 03:45 P.M. and concluded at 04:30 P.M. The necessary arrangements are in place to publish the audited financial results in the newspapers. The said financial results will also be available on company’s website https://indrayani.com and also on BSE website https://www.bseindia.com/stock- share-price /indrayani-biotechltd/i/n5d26r4a4n5i/b . Kindly take the same on records. Thanking You Yours Faithfully For Indrayani Biotech Limited. Swaminathan Govindarajan Whole-time Director DIN:02481041 Block 1, 33, SIDCO Electronic Complex, Thiru Vi Ka Industrial Estate, Guindy, Chennai 600032 Ph: +91-44-2/ 4+914-464-322750521416 | www.indrayani.com | info@indrayani.com | CIN: L40100TN1992PLC129301 VENKATESH & CO Chartered Accountants INDIA Independent Auditor’s Report on Consolidated Annual Financial Results of the company pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 To the Board of Directors Indrayani Biotech Limited Report on the Audit of the Consolidated Financial Results Qualified Opinion We have audited the accompanying Consolidated annual financial results of Indrayani Biotech Limited (Holding company) and its subsidiaries (holding company and its subsidiaries together referred to as “the Group”) for the year ended 31°t March, 2026, attached herewith, being submitted by the holding company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations”). Attentionis drawn to the fact that the consolidated figuresfor the corresponding year ended 31t March, 2026 as reported in these financial results have been approved by the holding company’s Board of Directors, but have not been subjected to audit/review. In our opinion and to the best of our information and according to the explanations given to us, and based on the consideration of the reports of the other auditorson separate financial statements/ financial information of subsidiaries, associates and jointly controlled entities, the Statement: a) includes the results of the Entities as annexed in Annexure — I and b) is presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in this regard; and subject to the matters in the basis of qualified opinion para, give a true and fair viewin conformity with the recognition and measurement principles laid down in the applicable accounting standards and other accounting principles generally accepted in India of Consolidated total comprehensive income [comprising of net profit and other comprehensive income (loss)] and other financial information of the Group for the year ended 31t March 2026. “SRIRANGA", New No.151, Mambalam High Road, T.Nagar, Chennai - 600 017. Telefax : 2814 4763/64/65/66 Email : venkateshandco@gmail.com VENKATESH & CO Chartered Accountants INDIA Basis of Qualified Opinion: . We draw attention to Note No. 11-A,8-Band 10 to the Consolidated Financial Statements regarding Loans , Other Current Asset and Trade Receivable Wherein the balances are subject to confirmation and reconciliation. We are unable to ascertain the consequential impact, if any, on the Consolidated Financial Statements. . In consolidation of accounts the following subsidiaries are compiled based on the INDIAN GAAP and not in accordance with the IND AS. The impact on the consolidated Profit and loss account on account of the same is not ascertainable. a. Matrix Boilers Private Limited b. Kniss Laboratories Private Limited . In respect of One Subsidiary namely HSL Prime Properties Private Limited, the auditor has stated the following in the Basis for Qualified Opinion Para., The Company has not obtained or provided balance confirmations in respect of all trade crediitors aggregating to Rs. 61,82,938 as at 31 March 2026, representing approximately 41% of the total liabilities of the Company. Consequently, we were unable to obtain sufficient appropriate audit evidence regarding the existence, completeness and accuracy of these balances through external confirmations or byp erforming alternative audit procedures. Accordingly, we were unable to determine whether any adjustments might have been necessary In respect of the aforesaid trade creditor balances and the corresponding elements of the financial statements. We conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143 (10) of the Companies Act, 2013 (the Act). Our responsibilities under those Standards are further describedin the Auditor's Responsibilities for the Audit of the Consolidated Financial Results section of our report. We are independent of the holding company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the finandal results under the provisions of the Companies Act, 2013 and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us and other auditors in terms of their reports referred to in “Other Matter” paragraph below, is sufficient and appropriate to provide a basis for our opinion. “SRIRANGA", New No.151, Mambalam High Road, T.Nagar, Chennai - 600 017. Telefax : 2814 4763/64/65/66 Email : venkateshandco@gmail.com VENKATESH & CO BT Chartered Accountants Management'’s Responsibilities for the Consolidated Financial Results These Consolidated financial results have been prepared on the basis of the consolidated annual financial statements. The Holding Company’s Board of Directors are responsible for the preparation and presentation of these consolidated financial results that give a true and fair view of the net profit/ loss and other comprehensive income and other financial information of the Group in accordance with the Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The respective Board of Directors of the companies included in the Group are responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Group and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completeness of the accounting records, relevant to the preparation and presentation of the consolidated financial results that [Showing first 8,000 characters — download PDF for full document]